The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis
Open accessAbstract
Rationale: Ulcerative colitis (UC), a typical kind of inflammatory bowel disease (IBD), is an idiopathic chronic intestinal inflammation.Conventional therapeutic strategies mainly focus on the rebalance of pro-inflammation and anti-inflammation cytokines, whereas targeting damaged intestinal barriers, imbalanced intestinal microbiota and dysregulated mucosal immune responses in UC remain a big challenge.The objective of this study was to develop turmeric-derived nanovesicles (TNVs) for alleviation of colitis and explore the underlying mechanisms.Methods: TNVs were isolated and purified through differential centrifugation.The targeted ability was evaluated on the dextran sulfate sodium (DSS)-induced mouse model by IVIS imaging system.The anti-inflammation efficacy was studied in lipopolysaccharide (LPS)-induced macrophages and DSS-induced acute and chronic colitic mouse model.In addition, the influence of TNVs on the intestinal microbiota was investigated via 16S rRNA microbiome sequence and the condition of macrophage polarization after TNVs treatment was analyzed by flow cytometry.Results: TNVs were isolated and characterized as nano-size spheroids.The IVIS imaging experiment indicated that orally administrated TNVs could accumulate in the inflamed colon sites and exhibited superior anti-inflammatory activity both in vitro and in vivo.The 16S rRNA sequencing suggested the important role of TNVs in the regulation of gut microbiota.Further, TNVs could promote the transformation of M1 phenotype to M2 macrophages and restore the damaged intestinal epithelium barrier to exert the anti-colitis efficacy.Conclusion: Collectively, oral administration of TNVs exhibited excellent anti-inflammatory efficacy through restoring the damaged intestinal barrier, regulating the gut microbiota and reshaping the macrophage phenotype.This study sheds light on the application of natural exosome-like nanovesicles for the treatment of UC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Murray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
The global burden of IBD: from 2015 to 2025
Kaplan, G. G. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.150 · Cited by 2,639
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
Epidemiology and risk factors for IBD
Ananthakrishnan, A. N. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.34 · Cited by 1,741
Chemically induced mouse models of acute and chronic intestinal inflammation
Wirtz, S., Popp, V., Kindermann, M., Gerlach, K., Weigmann, B., Fichtner-Feigl, S., & Neurath, M. F. (2017) · Nature Protocols · doi:10.1038/nprot.2017.044 · Cited by 1,575
Gut microbiota in the pathogenesis of inflammatory bowel disease
Nishida, A., Inoue, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0813-5 · Cited by 1,377
Extracellular vesicles for drug delivery.
Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.006 · Cited by 1,319
Exosome Theranostics: Biology and Translational Medicine
He, C., Zheng, S., Luo, Y., & Wang, B. (2018) · Theranostics · doi:10.7150/thno.21945 · Cited by 1,249
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Kaplan, G. G., & Ng, S. C. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.020 · Cited by 1,224
Manichanh, C., Borruel, N., Casellas, F., & Guarner, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.152 · Cited by 1,160
Plant-derived exosomal MicroRNAs shape the gut microbiota
Teng, Y., Ren, Y., Sayed, M., Hu, X., Lei, C., Kumar, A., Hutchins, E., Mu, J., Deng, Z., Luo, C., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.10.001 · Cited by 1,027
Zhang, M., Viennois, E., Prasad, M., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.018 · Cited by 1,026
Microbial genes and pathways in inflammatory bowel disease
Schirmer, M., Garner, A., Vlamakis, H., & Xavier, R. J. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0213-6 · Cited by 956
Current and emerging therapeutic targets for IBD
Neurath, M. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.208 · Cited by 691
Emerging role of extracellular vesicles in inflammatory diseases
Buzas, E. I., György, B., Nagy, G., Falus, A., & Gay, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.19 · Cited by 677
Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth
Cao, M., Yan, H., Han, X., Weng, L., Wei, Q., Sun, X., Lu, W., Wei, Q., Ye, J., Cai, X., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0817-4 · Cited by 552
Cellular and molecular mechanisms of curcumin in prevention and treatment of disease
Patel, S. S., Acharya, A., Ray, R. S., Agrawal, R., Raghuwanshi, R., & Jain, P. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1552244 · Cited by 511
Landy, J., Ronde, E., English, N., Clark, S. K., Hart, A. L., Knight, S. C., Ciclitira, P. J., & Al-Hassi, H. O. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i11.3117 · Cited by 507
Deng, Z., Rong, Y., Teng, Y., Mu, J., Zhuang, X., Tseng, M., Samykutty, A., Zhang, L., Yan, J., Miller, D., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.01.025 · Cited by 488
Chemokine-Induced Macrophage Polarization in Inflammatory Conditions
Ruytinx, P., Proost, P., Van Damme, J., & Struyf, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01930 · Cited by 450
Singh, S., Murad, M. H., Fumery, M., Dulai, P. S., & Sandborn, W. J. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.01.008 · Cited by 375
Wang, Q., Ren, Y., Mu, J., Egilmez, N. K., Zhuang, X., Deng, Z., Zhang, L., Yan, J., Miller, D., & Zhang, H.-G. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3095 · Cited by 366
Drug delivery strategies in the therapy of inflammatory bowel disease
Lautenschläger, C., Schmidt, C., Fischer, D., & Stallmach, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.001 · Cited by 291
Evolution and clinical translation of drug delivery nanomaterials
Hassan, S., Prakash, G., Bal Ozturk, A., Saghazadeh, S., Farhan Sohail, M., Seo, J., Remzi Dokmeci, M., Zhang, Y. S., & Khademhosseini, A. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.008 · Cited by 288
Ryan, F. J., Ahern, A. M., Fitzgerald, R. S., Laserna-Mendieta, E. J., Power, E. M., Clooney, A. G., O’Donoghue, K. W., McMurdie, P. J., Iwai, S., Crits-Christoph, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15342-5 · Cited by 285
Zhang, S., Langer, R., & Traverso, G. (2017) · Nano Today · doi:10.1016/j.nantod.2017.08.006 · Cited by 250
Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety
Dubinsky, M. C. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00344-1 · Cited by 249
Xu, X.-H., Yuan, T.-J., Dad, H. A., Shi, M.-Y., Huang, Y.-Y., Jiang, Z.-H., & Peng, L.-H. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c02530 · Cited by 233
Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer
Wang, Z., Li, S., Cao, Y., Tian, X., Zeng, R., Liao, D.-F., & Cao, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9875298 · Cited by 219
Gong, Z., Zhao, S., Zhou, J., Yan, J., Wang, L., Du, X., Li, H., Chen, Y., Cai, W., & Wu, J. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.004 · Cited by 212
Self-citationLi, C., Zhao, Y., Cheng, J., Guo, J., Zhang, Q., Zhang, X., Ren, J., Wang, F., Huang, J., Hu, H., et al. (2019) · Advanced Science · doi:10.1002/advs.201900610 · Cited by 209
Singla, V., Pratap Mouli, V., Garg, S. K., Rai, T., Choudhury, B. N., Verma, P., Deb, R., Tiwari, V., Rohatgi, S., Dhingra, R., et al. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.08.006 · Cited by 195
Nanotechnology for modern medicine: next step towards clinical translation
Sindhwani, S., & Chan, W. C. W. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13254 · Cited by 185
Garlic exosome-like nanoparticles reverse high-fat diet induced obesity via the gut/brain axis
Sundaram, K., Mu, J., Kumar, A., Behera, J., Lei, C., Sriwastva, M. K., Xu, F., Dryden, G. W., Zhang, L., Chen, S., et al. (2022) · Theranostics · doi:10.7150/thno.65427 · Cited by 176
Liu, P., Gao, C., Chen, H., Vong, C. T., Wu, X., Tang, X., Wang, S., & Wang, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.003 · Cited by 160
Self-citationDiagnosis by extracellular vesicles
Théry, C. (2015) · Nature · doi:10.1038/nature14626 · Cited by 158
Evertsz, F. B., Nieuwkerk, P. T., Stokkers, P. C. F., Ponsioen, C. Y., Bockting, C., Sanderman, R., & Sprangers, M. A. G. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.11.007 · Cited by 146
Liu, B., Li, X., Yu, H. V., Shi, X., Zhou, Y., Alvarez, S., Naldrett, M. J., Kachman, S. D., Ro, S., Sun, X., et al. (2021) · Theranostics · doi:10.7150/thno.60265 · Cited by 141
Self-citationA State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD
Chudy‐Onwugaje, K., Christian, K. E., Farraye, F. A., & Cross, R. K. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy327 · Cited by 133
Hall, L. J., Faivre, É., Quinlan, A., Shanahan, F., Nally, K., & Melgar, S. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1240-3 · Cited by 118
Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
Hoentjen, F., & Bodegraven, A. A. V. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2067 · Cited by 115
Wu, M.-Y., Liu, L., Wang, E., Xiao, H., Cai, C.-Z., Wang, J., Su, H., Wang, Y., Tan, J., Zhang, Z., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1741332 · Cited by 101
Self-citationZhou, Y. Y., Gao, C., Vong, C. T., Tao, H., Li, H., Wang, S., & Wang, Y. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15773 · Cited by 91
Self-citationCurrent Status of M1 and M2 Macrophages Pathway as Drug Targets for Inflammatory Bowel Disease
Seyedizade, S. S., Afshari, K., Bayat, S., Rahmani, F., Momtaz, S., Rezaei, N., & Abdolghaffari, A. H. (2020) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-020-00576-4 · Cited by 78
Telomere shortening in the colonic mucosa of patients with ulcerative colitis
Kinouchi, Y., Hiwatashi, N., Chida, M., Nagashima, F., Takagi, S., Maekawa, H., & Toyota, T. (1998) · Journal of Gastroenterology · doi:10.1007/s005350050094 · Cited by 74
Henning, S. M., Zhang, Y., Seeram, N. P., Lee, R., Wang, P., Bowerman, S., & Heber, D. (2010) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2010.530595 · Cited by 63
Martinez, B., Dailey, F. E., Almario, C. V., Keller, M. S., Desai, M., Dupuy, T. P., Mosadeghi, S., Whitman, C. B., Lasch, K. L., Ursos, L., et al. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001110 · Cited by 63
Myeloperoxidase activity of the large intestine in an equine model of acute colitis
McConnico, R. S., Weinstock, D., Poston, M. E., & Roberts, M. C. (1999) · American Journal of Veterinary Research · doi:10.2460/ajvr.1999.60.07.807 · Cited by 63
Update on the etiology, pathogenesis and diagnosis of ulcerative colitis
Hanauer, S. B. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0031 · Cited by 61
Identification, isolation and analysis of human gut-associated lymphoid tissues
Jørgensen, P. B., Fenton, T. M., Mörbe, U., Riis, L. B., Jakobsen, H. L., Nielsen, O. H., & Agace, W. W. (2021) · Nature Protocols · doi:10.1038/s41596-020-00482-1 · Cited by 51
Cytokines in Inflammatory Bowel Disease
Engel, M. A., & Neurath, M. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8256-7_15 · Cited by 14
Cited by
The emerging role of oxidative stress in inflammatory bowel disease
Muro, P., Zhang, L., Li, S., Zhao, Z., Jin, T., Mao, F., & Mao, Z. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1390351 · Cited by 279
Applications of Plant-Derived Extracellular Vesicles in Medicine
Zhu, Y., Zhao, J., Ding, H., Qiu, M., Xue, L., Ge, D., Wen, G., Ren, H., Li, P., & Wang, J. (2024) · MedComm · doi:10.1002/mco2.741 · Cited by 75
Self-citation
Metadata
- Authors
- Gao, C., Zhou, Y., Chen, Z., Li, H., Xiao, Y., Hao, W., Zhu, Y., Vong, C. T., Farag, M. A., Wang, Y., & Wang, S.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2022
- Volume
- 12
- Issue
- 12
- Pages
- 5596-5614
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W4285817578
- Cited by
- 278
- References
- 56
- FWCI
- 26.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.